The GB Sciences Technology Suite

GB Sciences’ pioneering self-contained growing unit isolates and protects the plants growing inside while generating ideal growing environments to ensure high quality, purity, and consistency.

TissueBLOX™

The tissue culture incubator is programmed to regulate lighting, temperature, and humidity to facilitate cell multiplication and the formation of embryos and shoots from the sterile explants.

GrowBLOX™

GB Sciences’ pioneering self-contained growing unit that isolates and protects the plants growing inside while generating ideal growing environments.

CureBLOX™

The CureBLOX™ module enables us to eliminate the risk of mold growth and ensure that the chemical profile of our products is consistent from harvest to harvest.

 

Our novel approach to cannabis-based medicine

Because patients deserve safe and standardized therapies.

Big Data Analysis

Under the supervision of our chief science officer, aggregated data from GB Sciences’ grow operations and patient treatment plans is collected and analyzed in a perennial feedback loop. This enables us to conduct product efficacy studies and clinical trials designed to improve patient outcomes and advance our therapeutic knowledge.

analyst

GBS-ciences-apothecary2

The Apothecary™
by GB Sciences

Discover how GB Sciences uses biometric and other advanced technologies to authenticate patient eligibility, simplify order processing, and enhance security so we can focus on what’s important: patient care.

Subscribe to Our Newsletter

Receive our white papers, articles, and announcements as they are being published by signing up for our monthly newsletter.

clipboard
parallax layerparallax layerparallax layerparallax layerparallax layer

A Peek into The Apothecary™

We use biometric technology and computer automation so we can focus on what matters most: the patient.
GB Sciences is playing an active role in transforming the cannabis industry and the biopharmaceutical industries so they will be like one in better serving the needs of patients.
Dr. Andrea Small-Howard, Chief Science Officer

andrea

Andrea Small-Howard, PhD, MBA,  leverages broad biopharmaceutical industry knowledge and contacts in her current dual roles as the Chief Science Officer and member of the Board of Directors at GB Sciences, Inc.

white-papers

Take a journey into the endocannabinoid system. Learn how different blends of cannabinoids target specific medical conditions, and why this primordial system is changing our approach to patient care.

phone-trans-frontpage

At GB Sciences, our patients will participate in creating our next advances in cannabinoid therapies by simply providing feedback during their treatment through our proprietary smartphone application.

GB Sciences in the News

Subscribe to Our Newsletter

Receive our white papers, articles, and announcements as they are being published by signing up for our monthly newsletter.

x